Tertomotide

Tertomotide is a 16-amino acid peptide based on the 616‑626 position fragment of human [telomerase reverse transcriptase] protein. It was originally developed as a peptide vaccine for cancer, as it can trigger immune attack against cancer cells which overexpress telomerase, a common mutation found in malignant tumors. However, it does not block telomerase activity in healthy tissue and has been found to produce various useful activities in its own right including antiviral, antiinflammatory and antidepressant effects, and has been trialled for numerous other medical applications including Alzheimer's disease as well as its original role in the treatment of cancer.